E-LIB Suche - Ergebnisse für: Liszkay, Gabriella

1

COLUMBUS 7-year update: A randomized, open-label, phase III..:

Schadendorf, Dirk ; Dummer, Reinhard ; Flaherty, Keith T....
European Journal of Cancer. 204 (2024) - p. 114073 , 2024

Link: https://doi.org/10.1016/..

2

A plain language summary of the 5-year update from part 1 o..:

Dummer, Reinhard ; Flaherty, Keith T ; Robert, Caroline...
Future Oncology. 19 (2023) 16 - p. 1091-1098 , 2023

Link: https://doi.org/10.2217/..

3

Significant improvement in melanoma survival over the last ..:

Liszkay, Gabriella ; Benedek, Angela ; Polgár, Csaba...
Journal of the European Academy of Dermatology and Venereology. 37 (2023) 5 - p. 932-940 , 2023

Link: https://doi.org/10.1111/..

4

Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in..:

Eikenes, Grethe ; Liszkay, Gabriella ; Balatoni, Tímea...
Cancers. 15 (2023) 15 - p. 3966 , 2023

Link: https://doi.org/10.3390/..

5

Atezolizumab, vemurafenib, and cobimetinib in patients with..:

Dummer, Reinhard ; Queirolo, Paola ; Gerard Duhard, Pauline...
The Lancet Oncology. 24 (2023) 12 - p. e461-e471 , 2023

Link: https://doi.org/10.1016/..

6

RETRACTED: Atezolizumab, vemurafenib, and cobimetinib in pa..:

Dummer, Reinhard ; Queirolo, Paola ; Abajo Guijarro, Ana Maria...
The Lancet Oncology. 23 (2022) 9 - p. 1145-1155 , 2022

Link: https://doi.org/10.1016/..

7

Corrigendum to 'Quality of life in patients with BRAF-mutan..:

Gogas, Helen ; Dummer, Reinhard ; Ascierto, Paolo A....
European Journal of Cancer. 160 (2022) - p. 287-288 , 2022

Link: https://doi.org/10.1016/..

8

HLA Class I Downregulation in Progressing Metastases of Mel..:

Ladányi, Andrea ; Hegyi, Barbara ; Balatoni, Tímea...
Pathology and Oncology Research. 28 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

9

Atezolizumab for the treatment of advanced recurrent basal ..:

Küronya, Zsófia ; Danyi, Tímea ; Balatoni, Tímea...
Journal of Medical Case Reports. 16 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

10

The Role of Stereotactic Radiotherapy in the Management of ..:

Kispál, Mihály ; Jánváry, Levente Zsolt ; Balatoni, Tímea...
Pathology and Oncology Research. 28 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

11

Changing Trends in Melanoma Incidence and Decreasing Melano..:

Liszkay, Gabriella ; Kiss, Zoltan ; Gyulai, Roland...
Frontiers in Oncology. 10 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

12

Quality of life in patients with BRAF-mutant melanoma recei..:

Gogas, Helen ; Dummer, Reinhard ; Ascierto, Paolo A....
European Journal of Cancer. 152 (2021) - p. 116-128 , 2021

Link: https://doi.org/10.1016/..

13

Predictive and Prognostic Value of BRAF and NRAS Mutation o..:

Liszkay, Gabriella ; Mátrai, Zoltán ; Czirbesz, Kata...
Cancers. 13 (2021) 13 - p. 3302 , 2021

Link: https://doi.org/10.3390/..

14

5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV6..:

Ascierto, Paolo A. ; Dréno, Brigitte ; Larkin, James...
Clinical Cancer Research. 27 (2021) 19 - p. 5225-5235 , 2021

Link: https://doi.org/10.1158/..

15

Improving Quality Indicator of Melanoma Management – Change..:

Várnai, Máté ; Kiss, Zoltán ; Gyulai, Rolland...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..